187 related articles for article (PubMed ID: 29305737)
1. Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation.
Quigley G; Al Ani M; Nadir A
Dig Dis Sci; 2018 Feb; 63(2):529-532. PubMed ID: 29305737
[No Abstract] [Full Text] [Related]
2. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.
Trauner M; Nevens F; Shiffman ML; Drenth JPH; Bowlus CL; Vargas V; Andreone P; Hirschfield GM; Pencek R; Malecha ES; MacConell L; Shapiro D
Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):445-453. PubMed ID: 30922873
[TBL] [Abstract][Full Text] [Related]
4. [New name and new treatments for primary biliary cholangitits].
Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
[TBL] [Abstract][Full Text] [Related]
5. Clarification of Obeticholic Acid Dosing: Response to "Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation" by Quigley et al.
Feng C
Dig Dis Sci; 2018 Jul; 63(7):1980-1981. PubMed ID: 29744771
[No Abstract] [Full Text] [Related]
6. Stratified medicine and primary biliary cholangitis.
Mells GF; Jones DE
Lancet Gastroenterol Hepatol; 2017 May; 2(5):319-321. PubMed ID: 28397694
[No Abstract] [Full Text] [Related]
7. [In process].
Christ MM
Med Monatsschr Pharm; 2017 Mar; 40(3):132-3. PubMed ID: 29952488
[No Abstract] [Full Text] [Related]
8. Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?
Wetten A; Jones DEJ; Dyson JK
Expert Opin Pharmacother; 2021 Oct; 22(15):1949-1953. PubMed ID: 34121570
[No Abstract] [Full Text] [Related]
9. Novel Treatment Strategies for Primary Biliary Cholangitis.
Parés A
Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
[TBL] [Abstract][Full Text] [Related]
10. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
11. Primary Biliary Cholangitis: advances in management and treatment of the disease.
Invernizzi P; Floreani A; Carbone M; Marzioni M; Craxi A; Muratori L; Vespasiani Gentilucci U; Gardini I; Gasbarrini A; Kruger P; Mennini FS; Ronco V; Lanati E; Canonico PL; Alvaro D
Dig Liver Dis; 2017 Aug; 49(8):841-846. PubMed ID: 28546061
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification and treatment of primary biliary cholangitis.
Martínez J; Aguilera L; Albillos A
Rev Esp Enferm Dig; 2019 Jan; 111(1):63-70. PubMed ID: 30338693
[TBL] [Abstract][Full Text] [Related]
13. Primary biliary cholangitis.
Lleo A; Wang GQ; Gershwin ME; Hirschfield GM
Lancet; 2020 Dec; 396(10266):1915-1926. PubMed ID: 33308474
[TBL] [Abstract][Full Text] [Related]
14. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.
Suraweera D; Rahal H; Jimenez M; Viramontes M; Choi G; Saab S
Liver Int; 2017 Dec; 37(12):1877-1886. PubMed ID: 28517369
[TBL] [Abstract][Full Text] [Related]
15. Old and new treatments for primary biliary cholangitis.
Chascsa D; Carey EJ; Lindor KD
Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
[TBL] [Abstract][Full Text] [Related]
16. Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid.
Londoño MC; Díaz-González Á
Liver Int; 2022 Nov; 42(11):2356-2359. PubMed ID: 36162085
[No Abstract] [Full Text] [Related]
17. Cheno and urso compared and contrasted.
Dowling RH
Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
[No Abstract] [Full Text] [Related]
18. Obeticholic Acid: First Global Approval.
Markham A; Keam SJ
Drugs; 2016 Aug; 76(12):1221-6. PubMed ID: 27406083
[TBL] [Abstract][Full Text] [Related]
19. Geoepidemiology and changing mortality in primary biliary cholangitis.
Floreani A; Tanaka A; Bowlus C; Gershwin ME
J Gastroenterol; 2017 Jun; 52(6):655-662. PubMed ID: 28365879
[TBL] [Abstract][Full Text] [Related]
20. Current Treatment Options for Primary Biliary Cholangitis.
Wong KA; Bahar R; Liu CH; Bowlus CL
Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
